Nu Skin Seeks Shareholder Approval for Significant Equity Incentive Plan Expansion

summarizeSummary

Nu Skin is holding its annual meeting, seeking approval for a substantial increase in its equity incentive plan share reserve, which would significantly increase potential shareholder dilution, alongside routine governance matters and previously announced executive changes.

check_boxKey Events

• Annual Meeting Scheduled

  The Annual Meeting of Stockholders will be held on May 28, 2026, to vote on the election of nine directors, an advisory vote on executive compensation, approval of the Amended and Restated 2024 Omnibus Incentive Plan, and ratification of PricewaterhouseCoopers LLP as the independent auditor.

• Significant Equity Incentive Plan Expansion Proposed

  Shareholders are asked to approve an amendment to the 2024 Omnibus Incentive Plan, increasing the authorized shares by 2,850,000. This would raise the total shares available for awards to 6,019,641 and increase the fully-diluted overhang from 10.5% to 14.9%.

• Executive Compensation Reflects Mixed Performance

  For 2025, executive cash incentive awards tied to financial goals (adjusted revenue and operating income) were not earned due to macroeconomic pressures and business transformation headwinds. However, strategic goals were partially achieved (21.9% payout), and 2025 performance-based restricted stock units (PRSUs) were earned at 200% for one tranche, 68% for another, and 0% for a third.

• Executive Leadership Changes Detailed

  The filing reiterates the resignation of James D. Thomas as CFO on March 17, 2026, and the appointment of Chelsea K. Lantz as Interim CFO on March 18, 2026. It also notes the promotion of Chayce D. Clark to EVP, COO, and Chief Legal Officer in March 2026, accompanied by an increase in his annual salary to $650,000 and target long-term incentive award value to $2,362,500.

auto_awesomeAnalysis

Nu Skin Enterprises is seeking shareholder approval for a substantial increase in its Amended and Restated 2024 Omnibus Incentive Plan, requesting an additional 2,850,000 shares. This would raise the total shares available for equity awards to over 6 million and increase the fully-diluted overhang from 10.5% to 14.9%. While the company states this is crucial for attracting and retaining talent and aligning interests, this level of potential dilution is significant, especially in the context of the company's recent financial performance, which included a 14% revenue drop in 2025 and missed financial targets for executive cash incentives. Shareholders will also vote on the election of directors, an advisory resolution on executive compensation, and the ratification of the independent auditor. The filing reiterates recent executive changes, including the CFO's resignation and the promotion of Chayce D. Clark to COO, which were previously disclosed.